BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Takayama K, Furusyo N, Ogawa E, Ikezaki H, Shimizu M, Murata M, Hayashi J. Direct-acting antiviral-based triple therapy on alpha-fetoprotein level in chronic hepatitis C patients. World J Gastroenterol 2015; 21(15): 4696-4706 [PMID: 25914481 DOI: 10.3748/wjg.v21.i15.4696]
URL: https://www.wjgnet.com/1007-9327/full/v21/i15/4696.htm
Number Citing Articles
1
Marco Spadaccini, Ana Lleo, Roberto Ceriani, Giovanni Covini, Lorenza Rimassa, Guido Torzilli, Luca Di Tommaso, Alessio Aghemo. Alpha-fetoprotein screening in patients with hepatitis C-induced cirrhosis who achieved a sustained virologic response in the direct-acting antiviral agents eraHepatobiliary & Pancreatic Diseases International 2018; 17(6): 570 doi: 10.1016/j.hbpd.2018.10.006
2
Hanan Mahmoud Fayed, Hasan Sedeek Mahmoud, Abdallah Elaiw Mohamed Ali. <p>The Utility of Retinol-Binding Protein 4 in Predicting Liver Fibrosis in Chronic Hepatitis C Patients in Response to Direct-Acting Antivirals</p>Clinical and Experimental Gastroenterology 2020; : 53 doi: 10.2147/CEG.S229689
3
Tung Huynh, Ke-Qin Hu. Direct acting antiviral-induced dynamic reduction of serum α fetoprotein in hepatitis C patients without hepatocellular carcinomaFrontiers of Medicine 2019; 13(6): 658 doi: 10.1007/s11684-019-0707-7
4
Kelvin Nguyen, Melissa Jimenez, Nima Moghadam, Crystal Wu, Alex Farid, Jonathan Grotts, David Elashoff, Gina Choi, Francisco A. Durazo, Mohamed M. El-Kabany, Steven-Huy B. Han, Sammy Saab. Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting AntiviralsJournal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2016.00057